September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Ocular Microbiome: Fact or Fiction?
Author Affiliations & Notes
  • Stephanie Wan
    Optometry, UC Berkeley, Berkeley, California, United States
  • Aaron Sullivan
    Optometry, UC Berkeley, Berkeley, California, United States
  • Peyton Shieh
    Chemistry, UC Berkeley, Berkeley, California, United States
  • David Evans
    Optometry, UC Berkeley, Berkeley, California, United States
    College of Pharmacy, Touro University, Vallejo, California, United States
  • Carolyn Bertozzi
    Chemistry, Stanford Univeristy, Stanford, California, United States
  • Suzanne M J Fleiszig
    Optometry, UC Berkeley, Berkeley, California, United States
  • Footnotes
    Commercial Relationships   Stephanie Wan, None; Aaron Sullivan , None; Peyton Shieh, None; David Evans, None; Carolyn Bertozzi, None; Suzanne Fleiszig, None
  • Footnotes
    Support  NIH Grants RO1-EY02060, T32-EY007043
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephanie Wan, Aaron Sullivan, Peyton Shieh, David Evans, Carolyn Bertozzi, Suzanne M J Fleiszig; Ocular Microbiome: Fact or Fiction?. Invest. Ophthalmol. Vis. Sci. 2016;57(12):No Pagination Specified.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Whether the ocular surface hosts a live microbiome remains unresolved. High-throughput sequencing of the microbial 16s ribosomal gene predicts a rich abundance of microbes at the ocular surface. These methods, however, detect bacterial nucleic acid and not live microbes. Here, we tested the hypothesis that the ocular surface does not host a stable, metabolically active microbiome.

Methods : Methods involved addition of alkyne functionalized D-alanine (10mM), which incorporates into the cell wall of only metabolically active bacteria and is detected by addition of an azide fluorophore (copper catalyzed click chemistry), imaged using a confocal microscope. To confirm the method works on the eye, 3 mice were sacrificed, eyes enucleated, then deliberately inoculated with viable P. aeruginosa. In other experiments we explored if the eye can be stably colonized when deliberately inoculated. Mice were anesthetized before inoculating one eye with P. aeruginosa, S. aureus or a gram-positive commensal bacterium isolated from the mouse dermis. Mice were sacrificed after 24 h or 3 days. To collect tear fluid, 5μL of sterile PBS was added, then collected with a capillary tube. The conjunctiva and cornea were removed, homogenized, and bacteria enumerated by viable counts (all 3 are culturable).

Results : After inoculation with ~108 CFU of P. aeruginosa, S. aureus, or commensal skin bacteria, >99.99% of the original inoculum was cleared after 24 hours in the cornea, conjunctiva, and tear fluid (P<0.01). Similar results were obtained for P. aeruginosa and S. aureus after 3 days (>99.99% clearance, P < 0.0001) and when using a small inoculum (~104 CFU, >99.75% clearance, P<0.05). The D-alanine label detected metabolically active bacteria if they were deliberately added (11.00 ± 3.30 bacteria/image). Otherwise, metabolically active bacteria were rarely detected on the cornea (0.50 ± 0.27 bacteria/image, p=0.003).

Conclusions : The ocular surface of the healthy mouse quickly eradicated two bacterial pathogens at both high and low inocula, and also commensal skin bacteria, suggesting it is an inhospitable environment for microbes to colonize. Alkyne functionalized D-alanine is a useful novel method to label metabolically active bacteria on the eye. The sparsity of metabolically active bacteria on the mouse cornea suggests the absence of a stable, live microbiome. The presence of non-metabolically active bacteria remains a possibility.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×